Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In a new study, neuroscientists have found that raised blood pressure and diabetes in mid-life alter brain structure to slow thinking speed and memory.

Three scientists looking at a computer screen in an open plan office
Dr Xin You Tai, DPhil student, Dr Michele Veldsman, Postdoctoral Research Scientist in Cognitive Neurology and Masud Husain, Professor of Neurology and Cognitive Neuroscience

Looking at results from 22,000 volunteers in the UK Biobank who underwent brain scanning, the scientists found that raised blood pressure and diabetes significantly impaired the brain’s cognitive functions, specifically the performance of thinking speed and short-term memory.

Masud Husain, Professor of Neurology and Cognitive Neuroscience at the Nuffield Department of Clinical Neurosciences and lead investigator of the study, said, ‘For blood pressure, every mm of pressure in your arteries counts – even in people who aren’t on any treatment. For people who are on treatment, systolic blood pressures above 140 mm were associated with lower cognitive performance. The higher the pressure, the worse it is.’

Monitoring and treating even modestly raised blood pressure might make a difference to the structure of the brain and speed of thinking in mid-life, while also offering potential to reduce the risks of developing dementia later in life.
- Professor Masud Husain

The study, published in Nature Communications, shows the effects of blood pressure were strongest in people aged 44-69. Whereas in people aged above 70, the level of pressure did not have such an impact on the brain’s cognitive function.

These effects appear to be mediated by alterations in brain structure that were detected using new MRI brain scanning analysis techniques. The brain changes occurred in people with high blood pressure and diabetes, who were otherwise healthy individuals.

Some researchers have previously shown that blood pressure and diabetes in mid-life can increase the risk of developing dementia later in life. The new findings of the Oxford group reveal that these factors can also have a direct impact on cognitive performance in mid-life.

Dr. Michele Veldsman, Postdoctoral Research Scientist in Cognitive Neurology at the Department of Experimental Psychology and co-author of the study, said, ‘The MRI scans show that raised blood pressure and glucose seem to alter both the grey matter and the white matter connections in the brain.’

Dr. Xin You Tai, collaborator and DPhil student at the Nuffield Department of Clinical Neurosciences, said, ‘These changes seem to have a direct impact on the speed of thinking and short-term memory.’

The findings have important implications for brain health and may help neuroscientists answer how we can keep our brains healthy and more resilient as we get older.

Similar stories

Study reveals association between diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection, and other severe acute respiratory infections

New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

Visit from the Sir Jules Thorn Charitable Trust

Earlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.

Oxford receives £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. Our department will play a major role.